| 0 |
SCHIZENCEPHALY |
9 |
0.2000 |
| 1 |
CEREBRAL HAEMORRHAGE FOETAL |
9 |
0.1475 |
| 2 |
ANTITHROMBIN III DEFICIENCY |
1 |
0.0112 |
| 3 |
BONE FORMATION DECREASED |
1 |
0.0063 |
| 4 |
BLOOD MAGNESIUM INCREASED |
5 |
0.0055 |
| 5 |
SOMNOLENCE NEONATAL |
1 |
0.0051 |
| 6 |
XERODERMA |
1 |
0.0037 |
| 7 |
HUMAN HERPESVIRUS 6 ENCEPHALITIS |
1 |
0.0035 |
| 8 |
THERAPEUTIC PRODUCT EFFECT INCREASED |
3 |
0.0026 |
| 9 |
VITAMIN B1 DEFICIENCY |
1 |
0.0023 |
| 10 |
METASTASES TO KIDNEY |
1 |
0.0018 |
| 11 |
OSTEOGENESIS IMPERFECTA |
1 |
0.0017 |
| 12 |
PALATAL DISORDER |
1 |
0.0017 |
| 13 |
HYPERMAGNESAEMIA |
1 |
0.0015 |
| 14 |
FOETAL HEART RATE DECELERATION ABNORMALITY |
1 |
0.0014 |
| 15 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
1 |
0.0013 |
| 16 |
RESPIRATORY ALKALOSIS |
2 |
0.0012 |
| 17 |
DEVELOPMENTAL HIP DYSPLASIA |
1 |
0.0012 |
| 18 |
PULMONARY INFARCTION |
2 |
0.0008 |
| 19 |
RECTAL PROLAPSE |
1 |
0.0008 |
| 20 |
NECROTISING COLITIS |
1 |
0.0008 |
| 21 |
ABORTION INDUCED |
7 |
0.0007 |
| 22 |
ECHOCARDIOGRAM ABNORMAL |
1 |
0.0007 |
| 23 |
PERIPHERAL MOTOR NEUROPATHY |
1 |
0.0007 |
| 24 |
RESPIRATORY FAILURE |
45 |
0.0006 |
| 25 |
LIP DISORDER |
1 |
0.0005 |
| 26 |
ANORECTAL DISORDER |
1 |
0.0005 |
| 27 |
DERMAL CYST |
1 |
0.0004 |
| 28 |
DERMATITIS ACNEIFORM |
2 |
0.0003 |
| 29 |
ARTERIOSCLEROSIS CORONARY ARTERY |
2 |
0.0003 |
| 30 |
OLIGOHYDRAMNIOS |
1 |
0.0003 |
| 31 |
METASTASES TO SPINE |
1 |
0.0003 |
| 32 |
CONJUNCTIVAL HYPERAEMIA |
1 |
0.0003 |
| 33 |
IMMUNE-MEDIATED ENTEROCOLITIS |
1 |
0.0003 |
| 34 |
TORSADE DE POINTES |
2 |
0.0003 |
| 35 |
EXPOSURE VIA BREAST MILK |
1 |
0.0003 |
| 36 |
HYPERURICAEMIA |
1 |
0.0002 |
| 37 |
GASTROINTESTINAL PERFORATION |
1 |
0.0002 |
| 38 |
PARONYCHIA |
1 |
0.0002 |
| 39 |
BRONCHOSPASM |
3 |
0.0002 |
| 40 |
SUPRAVENTRICULAR TACHYCARDIA |
2 |
0.0002 |
| 41 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
2 |
0.0002 |
| 42 |
SKIN NECROSIS |
1 |
0.0002 |
| 43 |
SKIN LACERATION |
2 |
0.0002 |
| 44 |
CHOLECYSTITIS ACUTE |
1 |
0.0002 |
| 45 |
PERIPHERAL SENSORY NEUROPATHY |
1 |
0.0002 |
| 46 |
COVID-19 PNEUMONIA |
2 |
0.0002 |
| 47 |
INFUSION SITE PAIN |
2 |
0.0002 |
| 48 |
SARS-COV-2 TEST POSITIVE |
2 |
0.0002 |
| 49 |
CONDITION AGGRAVATED |
45 |
0.0001 |
| 50 |
ACUTE HEPATIC FAILURE |
2 |
0.0001 |
| 51 |
HYPOMAGNESAEMIA |
2 |
0.0001 |
| 52 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
1 |
0.0001 |
| 53 |
ACIDOSIS |
1 |
0.0001 |
| 54 |
LACTIC ACIDOSIS |
4 |
0.0001 |
| 55 |
MATERNAL EXPOSURE DURING PREGNANCY |
11 |
0.0001 |
| 56 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 57 |
HICCUPS |
1 |
0.0001 |
| 58 |
NAIL DISORDER |
1 |
0.0001 |
| 59 |
EXPOSURE DURING PREGNANCY |
7 |
0.0001 |
| 60 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 61 |
TOOTH ABSCESS |
1 |
0.0001 |
| 62 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
1 |
0.0001 |
| 63 |
VENTRICULAR EXTRASYSTOLES |
1 |
0.0001 |
| 64 |
VENTRICULAR FIBRILLATION |
1 |
0.0001 |
| 65 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
4 |
0.0001 |
| 66 |
FOETAL EXPOSURE DURING PREGNANCY |
7 |
0.0001 |
| 67 |
HYPERGLYCAEMIA |
3 |
0.0001 |
| 68 |
INJECTION SITE EXTRAVASATION |
1 |
0.0001 |
| 69 |
UNRESPONSIVE TO STIMULI |
2 |
0.0001 |
| 70 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 71 |
DRUG WITHDRAWAL SYNDROME NEONATAL |
1 |
0.0001 |
| 72 |
HEPATIC FAILURE |
2 |
0.0001 |
| 73 |
TOXIC EPIDERMAL NECROLYSIS |
1 |
0.0001 |
| 74 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 75 |
PNEUMOTHORAX |
1 |
0.0001 |
| 76 |
VENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 77 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 78 |
METASTASES TO LIVER |
1 |
0.0001 |
| 79 |
HYPOXIA |
2 |
0.0001 |
| 80 |
ELECTROCARDIOGRAM QT PROLONGED |
2 |
0.0001 |
| 81 |
MEDICATION ERROR |
3 |
0.0001 |
| 82 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 83 |
FEEDING DISORDER |
1 |
0.0000 |
| 84 |
TASTE DISORDER |
1 |
0.0000 |
| 85 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 86 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 87 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 88 |
INFUSION RELATED REACTION |
3 |
0.0000 |
| 89 |
FEBRILE NEUTROPENIA |
3 |
0.0000 |
| 90 |
TACHYCARDIA |
4 |
0.0000 |
| 91 |
HYPOKALAEMIA |
2 |
0.0000 |
| 92 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 93 |
INJECTION SITE URTICARIA |
1 |
0.0000 |
| 94 |
HYPOTENSION |
8 |
0.0000 |
| 95 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 96 |
NECK PAIN |
2 |
0.0000 |
| 97 |
TOXICITY TO VARIOUS AGENTS |
6 |
0.0000 |
| 98 |
HYPONATRAEMIA |
2 |
0.0000 |
| 99 |
FEELING HOT |
2 |
0.0000 |
| 100 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 101 |
NEUTROPENIA |
4 |
0.0000 |
| 102 |
BURNING SENSATION |
2 |
0.0000 |
| 103 |
HYPERKALAEMIA |
1 |
0.0000 |
| 104 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 105 |
PARAESTHESIA |
4 |
0.0000 |
| 106 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 107 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 108 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 109 |
CARDIAC DISORDER |
2 |
0.0000 |
| 110 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 111 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 112 |
LEUKOPENIA |
1 |
0.0000 |
| 113 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 114 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 115 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 116 |
THROMBOCYTOPENIA |
2 |
0.0000 |
| 117 |
STOMATITIS |
1 |
0.0000 |
| 118 |
PRODUCT USE ISSUE |
3 |
0.0000 |
| 119 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 120 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 121 |
HOT FLUSH |
1 |
0.0000 |
| 122 |
DECREASED APPETITE |
3 |
0.0000 |
| 123 |
CARDIAC FAILURE |
1 |
0.0000 |
| 124 |
TREMOR |
2 |
0.0000 |
| 125 |
URTICARIA |
2 |
0.0000 |
| 126 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 127 |
PYREXIA |
4 |
0.0000 |
| 128 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 129 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 130 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 131 |
MUSCLE SPASMS |
2 |
0.0000 |
| 132 |
BREAST CANCER |
1 |
0.0000 |
| 133 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 134 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 135 |
DYSPEPSIA |
1 |
0.0000 |
| 136 |
HEART RATE INCREASED |
1 |
0.0000 |
| 137 |
SINUSITIS |
1 |
0.0000 |
| 138 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 139 |
ERYTHEMA |
2 |
0.0000 |
| 140 |
PNEUMONIA |
3 |
0.0000 |
| 141 |
INFLUENZA |
1 |
0.0000 |
| 142 |
SEPSIS |
1 |
0.0000 |
| 143 |
DYSPNOEA |
5 |
0.0000 |
| 144 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 145 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 146 |
OFF LABEL USE |
7 |
0.0000 |
| 147 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 148 |
HYPERHIDROSIS |
1 |
0.0000 |
| 149 |
INSOMNIA |
2 |
0.0000 |
| 150 |
DRY SKIN |
1 |
0.0000 |
| 151 |
INFECTION |
1 |
0.0000 |
| 152 |
MALAISE |
3 |
0.0000 |
| 153 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 154 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 155 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 156 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 157 |
ANAEMIA |
1 |
0.0000 |
| 158 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 159 |
SOMNOLENCE |
1 |
0.0000 |
| 160 |
CONSTIPATION |
1 |
0.0000 |
| 161 |
BACK PAIN |
1 |
0.0000 |
| 162 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 163 |
VOMITING |
2 |
0.0000 |
| 164 |
FATIGUE |
3 |
0.0000 |
| 165 |
COUGH |
1 |
0.0000 |
| 166 |
PAIN |
2 |
0.0000 |
| 167 |
ASTHENIA |
1 |
0.0000 |
| 168 |
NAUSEA |
2 |
0.0000 |
| 169 |
ARTHRALGIA |
1 |
0.0000 |
| 170 |
RASH |
1 |
0.0000 |
| 171 |
DIZZINESS |
1 |
0.0000 |
| 172 |
DIARRHOEA |
1 |
0.0000 |
| 173 |
DEATH |
1 |
0.0000 |